CEBP 09 AM Call for Abstracts w/deadline 2008 Conference on Cancer Prevention - Washington, D.C.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Natarajan, A. T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Natarajan, A. T.
Cancer Epidemiology Biomarkers & Prevention Vol. 12, 388-389, April 2003
© 2003 American Association for Cancer Research


Letters to the Editor


 

Reply

A. T. Natarajan

Medical Genetics Centre, South-West Netherlands, Department of Radiation Genetics and Chemical Mutagenesis, Leiden University Medical Centre, 2300 RA Leiden, The Netherlands

This is with reference to the comments of Dr. R. J. Albertini on our study (Czene et al., 2002). The points raised by Dr. Albertini are relevant. We have clearly stated that in our report about the preliminary nature of this study, as well as that the possible exposures other than PO to the workers cannot be ruled out.

As regards to SCEs, this end point is only a reflection of an exposure to genotoxic agents and needs not directly lead to any genetic consequence. However, the increased frequencies of SCEs in workers in our study cannot be attributable to higher incorporation of BrdUrd in these cultures compared with the controls, because all these cultures were carried out under identical conditions and at the same time. It is very unlikely that control cultures had incorporated less BrdUrd, and the immunostaining did not show any visible difference between the controls and exposed.

Of course, it is ideal to look for stable chromosome aberrations, such as translocations, but this is not practical in such a study, as low PO exposures can induce only few chromatid types of aberrations, and only a small fraction can be transformed into chromosome types of aberrations.

We appreciate the concern by Dr. Albertini and agree that one should not rely only on the data on SCEs, especially in exercises aiming at cancer risk assessments after exposures to genotoxic agents.





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Natarajan, A. T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Natarajan, A. T.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online